Maximilian Lennartz
Overview
Explore the profile of Maximilian Lennartz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
87
Citations
552
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Viehweger F, Gusinde J, Leege N, Tinger L, Gorbokon N, Menz A, et al.
Hum Pathol
. 2025 Mar;
157:105757.
PMID: 40054585
Estrogen receptor (ER) is a ligand-activated transcription factor with a critical role in development and function of multiple organ systems and a well-established drug target for breast cancer. To comprehensively...
2.
Plage H, Frericks A, Hofbauer S, Furlano K, Weinberger S, Rossner F, et al.
BMC Urol
. 2025 Feb;
25(1):37.
PMID: 39979991
Purpose: We aimed to assess the impact of GATA3 binding protein (GATA3) gene copy number alterations on tumor aggressiveness, patient prognosis, and GATA3 protein expression in a large urothelial bladder...
3.
Caneve P, Schraps N, Moller K, Buyucek S, Lutz F, Chirico V, et al.
Ann Diagn Pathol
. 2025 Feb;
76:152448.
PMID: 39929118
Brachyury protein plays a role in defining the midline of bilaterian organisms. Commonly expressed in chordomas, brachyury immunohistochemistry is used to distinguish chordomas from their differential diagnoses. However, brachyury expression...
4.
Jansen K, Kornfeld L, Lennartz M, Rico S, Kind S, Reiswich V, et al.
Cancers (Basel)
. 2024 Dec;
16(23).
PMID: 39682238
Background/objectives: Carcinoembryonic antigen (CEA) is a cell-surface glycoprotein serving as a drug target, diagnostic marker, and serum marker for cancer monitoring. However, prevalence data on CEA expression in cancer tissues...
5.
Plage H, Furlano K, Hofbauer S, Rossner F, Schallenberg S, Elezkurtaj S, et al.
Int Urol Nephrol
. 2024 Dec;
PMID: 39680294
Purpose: Placental alkaline phosphatase (PLAP) is a protein with a poorly understood function that is normally only expressed in the placenta. In cancer, PLAP expression is a hallmark of germ...
6.
Gorbokon N, Wossner N, Ahlburg V, Plage H, Hofbauer S, Furlano K, et al.
J Pathol Clin Res
. 2024 Dec;
11(1):e70012.
PMID: 39668577
Homozygous 9p21 deletions usually result in a complete loss of S-methyl-5'-thioadenosine phosphorylase (MTAP) expression visualizable by immunohistochemistry (IHC). MTAP deficiency has been proposed as a marker for predicting targeted treatment...
7.
Buyucek S, Schraps N, Menz A, Lutz F, Chirico V, Viehweger F, et al.
Biomark Res
. 2024 Dec;
12(1):154.
PMID: 39658782
Background: Claudin-3 (CLDN3) participates in the formation of the tight-junctions (TJs) that regulate intercellular permeability. Altered CLDN3 expression has been linked to tumor progression in multiple tumor types. Despite its...
8.
Lutz F, Hornburg S, Moller K, Viehweger F, Schlichter R, Menz A, et al.
Hum Pathol
. 2024 Nov;
154:105695.
PMID: 39571690
PAX6 immunohistochemistry (IHC) was proposed as a tool to identify a pancreatic origin of neuroendocrine neoplasms (NENs). To evaluate the diagnostic utility of PAX6 IHC, a tissue microarray containing 19,214...
9.
Furlano K, Plage H, Hofbauer S, Weinberger S, Ralla B, Fendler A, et al.
BJUI Compass
. 2024 Nov;
5(11):1081-1089.
PMID: 39539567
Objective: There is a shortage of established prognostic biomarkers in bladder cancer. One candidate is tumour protein 63 (p63), a transcription factor of the p53 gene family that is expressed...
10.
Schraps N, Port J, Menz A, Viehweger F, Buyucek S, Dum D, et al.
Cancer Med
. 2024 Nov;
13(21):e70407.
PMID: 39533806
Backround: Anterior gradient 2 (AGR2) is a resident endoplasmic reticulum (ER) protein with a vital role in embryonal development, mucus maturation, tissue regeneration, and wound healing. Methods: To determine the...